跳至主要内容
临床试验/CTRI/2024/10/074611
CTRI/2024/10/074611尚未招募3 期

A Randomized Controlled Trial To Evaluate The Effect Of Bharangi Sarkara In Tamaka Shwasa W.S.R To Bronchial Asthma

Sri Dharmasthala Manjunatheshwara College of Ayurveda, Hospital and Research Centre1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年10月24日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
1. Teevra Vega Shwasa - Shwasa Krichrata (Dyspnoea)

研究概览

简要总结

This is a Randomized,open label,parallel group study comparing the safety and efficacy of Trial drug [group-A] Bharangi Sarkara 10g daily and the Controlled drug [group-B]  Tekaraja churna 12g daily for 30 days for 15 patients to each groups and will be conducted in Shri Dharmasthala Manjunatheshwara college of Ayurveda and Hospital, Kuthpady,Udupi, Karnataka, India. The Primary outcome measures will be assessed before and after the treatment using the Subjective parameters. The Secondary outcome measures will be assessed with objective parameteres like Peak flow meter test values, Chest expansion values, Sputum quantity before and after the treatment. Hence an effort has been planned through this clinical study to planned through this clinical study to prove the efficacy of Bharangi Sarkara as effective against Tamaka Shwasa w.s.r to Bronchial Asthma.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients fulfilling the diagnostic criteria.
  • Age eligibility for the study- 18 years to 70 years.
  • Mild intermittent, Mild persistent, Moderate persistent cases of Bronchial Asthma according to GINA guidelines for Asthma.

排除标准

  • Severe persisting Asthma according to Global Initiative for Asthma (GINA) guidelines.
  • Patient with history of congenital anatomical abnormalities of chest and respiratory system.
  • Subjects with uncontrolled diabetes mellitus were excluded (RBS more than 300 mg/dl)
  • Other systemic disorders which intervene the treatment.
  • Pregnant and lactating women.

结局指标

主要结局

1. Teevra Vega Shwasa - Shwasa Krichrata (Dyspnoea)

时间窗: 30 days

2. Dukhena Kapha nissaranam (Expectoration)

时间窗: 30 days

3. Ghurghuratwam (Wheezing)

时间窗: 30 days

4. Kasa (Cough)

时间窗: 30 days

次要结局

  • 1. Changes in Peak Flow Meter Test values(2. Chest Expansion (in centimeters): during inspiration and expiration)

研究者

发起方
Sri Dharmasthala Manjunatheshwara College of Ayurveda, Hospital and Research Centre
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

DR JYOTHSNAA K

Sri Dharmasthala Manjunatheshwara College of Ayurveda, Hospital and Research Centre,Kuthpady

研究点 (1)

Loading locations...

相似试验